- Filed
- May 14, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 7, 2025 | 16.1M sh |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $28.04M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $23.1M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $860K |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $1.06M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $10.44M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $10.95M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $51.5M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $53.18M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $51.5M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $53.18M |
| Short Term Investments | Q1 2025 · Dec 31, 2024 | $6.37M |
| Shares Diluted restated | Q1 2025 · Mar 31, 2024 | 16.05K sh |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$9.56M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $7.71M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $13.55M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.57 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.57 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $5.24M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$8.47M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$9.48M |